Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Autism Spectrum Disorder
NCT03183674Phase 1Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Oxytocin Spray with Placebo (2 arms). Primary endpoint: Eye tracking. Started Jul 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03183674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183674.